Clinical Trial Update: Risk Factors for Allo-immunization in Sickle Cell Disease

View source ↗

Summary

The clinical trial NCT03401125 investigating risk factors for allo-immunization in sickle cell disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Hanane EL KENZ | Conditions: Sickle Cell Disease | Status: WITHDRAWN